PD-L1 Expression in Unresectable Locally Advanced or Metastatic Skin Squamous Cell Carcinoma Treated with

Stefano Cavalieri1, Federica Perrone2, Massimo Milione2

  • 1Head and Neck Medical Oncology Unit, Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, Milan, Italy.

Oncology
|May 22, 2019
PubMed
Abstract

Insights

PD-L1 expression in the tumor microenvironment was linked to longer progression-free survival in patients with advanced skin squamous cell carcinoma treated with EGFR inhibitors. This suggests a potential biomarker for treatment response.

Area of Science:

  • Oncology
  • Immunology
  • Dermatology

Background:

  • Advanced skin squamous cell carcinoma (sSCC) often requires systemic therapy when surgery or irradiation are not options.
  • Epidermal growth factor receptor (EGFR) inhibitors and immune checkpoint blockers (ICBs) have demonstrated efficacy in R/M sSCC.
  • The predictive role of PD-L1 expression in response to anti-EGFR agents in sSCC remains to be fully elucidated.

Purpose of the Study:

  • To investigate the association between PD-L1 expression and treatment outcomes in patients with R/M sSCC receiving EGFR inhibitors.
  • To explore the prognostic significance of PD-L1 expression on tumor cells (TCs) and tumor-infiltrating lymphocytes (ICs).

Main Methods:

  • Retrospective analysis of 28 R/M sSCC patients treated with dacomitinib or chemotherapy plus cetuximab (2010-2016).
  • PD-L1 expression assessed via immunohistochemistry on TCs and ICs.
  • Correlation of PD-L1 status with progression-free survival (PFS), overall survival (OS), and response rates.

Main Results:

  • PD-L1 expression on ICs was associated with significantly longer PFS (7.5 months vs. 2.1 months, p=0.02).
  • No significant correlation was found between PD-L1 expression (TC or IC) and OS or response rates.
  • A minority of cases (15%) showed positivity for both TC and IC PD-L1 expression.

Conclusions:

  • PD-L1 expression in the tumor microenvironment (ICs) may serve as a predictive biomarker for improved PFS in R/M sSCC treated with EGFR inhibitors.
  • Further research into the interplay between EGFR and PD-1/PD-L1 pathways, potentially through combination therapies, is warranted.

Related Concept Videos

Renewal of Skin Epidermal Stem Cells01:12

Renewal of Skin Epidermal Stem Cells

The skin is divided into epidermis, dermis, and hypodermis, the skin's outermost, middle, and inner layers. The human epidermal layer regularly undergoes renewal, where old, dead cells are replaced by new cells. Epidermal stem cells or EpiSCs divide and differentiate to restore the lost cells. For the renewal process, some EpiSCs continuously self-renew. In contrast, few others differentiate into transit-amplifying cells, which later form prickle or spinous cells, followed by granular...
3.0K
Local Anesthetics: Common Agents and Their Applications01:23

Local Anesthetics: Common Agents and Their Applications

Local anesthetics (LAs) are commonly used for various applications in medical and dental procedures. Some of the common agents used are cocaine, lidocaine, and bupivacaine.
Cocaine is an ester of benzoic acid and methylecgogine. It is used to anesthetize and vasoconstrict locally. Currently, it is used primarily for topical applications. It is beneficial for surgeries on the upper respiratory tract, providing anesthesia and shrinking the mucosa. Cocaine in the form of cocaine hydrochloride is...
929
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
3.3K
Factors Influencing Microbial Growth: pH01:29

Factors Influencing Microbial Growth: pH

Microorganisms are classified as acidophiles, neutrophiles, or alkaliphiles based on their pH growth preferences, reflecting their adaptations to specific environments. Maintaining a stable intracellular pH is critical for macromolecular stability and enzymatic activity, which can be challenged by external pH variations.Neutrophiles, such as Escherichia coli, grow optimally between pH 5.5 and 8.0. These microorganisms inhabit neutral or slightly acidic environments and employ mechanisms like...
1.1K
Factors Influencing Microbial Growth: Temperature01:27

Factors Influencing Microbial Growth: Temperature

Microorganisms display remarkable adaptations, enabling them to thrive in diverse ecological niches across a wide range of temperatures. Temperature profoundly influences microbial growth by affecting enzymatic activity, membrane fluidity, and other cellular processes.Each microorganism operates within a specific temperature range defined by three cardinal points: minimum, optimum, and maximum. Below the minimum temperature, membranes lose fluidity, halting transport processes. Above the...
1.2K
Factors Influencing Microbial Growth: Osmolarity01:28

Factors Influencing Microbial Growth: Osmolarity

Osmolarity is the measure of solute concentration in a solution. It plays a critical role in determining water availability for organisms. Water moves across semipermeable membranes through osmosis, flowing from regions of lower solute concentration (more dilute) to regions of higher solute concentration (more concentrated).In high-solute environments, microbial cells lose water, leading to dehydration and inhibited growth. The extent to which water is available to microbes in such environments...
778